5-Alpha-Hydroxy-Laxogenin
A semi-synthetic derivative of laxogenin that constitutes most of what is actually sold under the 'laxogenin' name. Marketed as a natural anabolic with the same protein-synthesis claims, and with the same near-total absence of human evidence.
01 Overview
5-Alpha-hydroxy-laxogenin is a synthetically modified spirostanol added to sports supplements as a supposed non-hormonal anabolic. Analyses of commercial 'laxogenin' products have repeatedly found this derivative rather than natural laxogenin, raising questions about ingredient labelling.
As with laxogenin, the anabolic rationale rests on brassinosteroid cell studies, and there are no controlled human trials of body composition, strength, or safety. It is non-androgenic and not a scheduled steroid, but its status as a lawful dietary ingredient is disputed.
02 Mechanism
Proposed brassinosteroid-like activation of protein-synthesis pathways (Akt/mTOR) from cell-model data; non-androgenic and does not convert to sex hormones.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Label-typical | 50–100 mg/day | Oral | Common supplement dose; efficacy unproven. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Protein synthesis / recomposition (claimed)Same brassinosteroid-based rationale as laxogenin; no human data. | Unquantified in humans | Preclinical | |
| Non-hormonalNo androgen receptor activity or sex-hormone conversion expected. | No androgenic action | Preclinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Unknown safety and mislabellingNo human safety data; often sold mislabelled as natural laxogenin. | Mild | Unknown | Unconfirmed | |
| Mild GI upsetOccasional nausea. | Mild | Uncommon | Anecdotal |